Merck, Moderna share positive progress of potential skin cancer vaccine

A potential skin cancer vaccine being developed using the same technology behind COVID shots fared well in a small study, the drug companies said.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Kenilworth ,Warwickshire ,Stephane Bancel ,Moderna Inc ,Merck Co ,File Image ,Massachusetts Based Moderna ,New Jersey Based Merck ,Health ,News ,Cancer ,